Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
51.89%
Operating Margin
7.94%
Net Margin
-13.24%
Efficiency Metrics
Revenue per Expense Ratio
1.06
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
40.20%
Income Tax Rate
-29,600,000.0%
EPS
-0.7800000000
Balance Sheet Analysis
Current Ratio
2.30
Cash Ratio
0.88
Working Capital
$242.61M
Debt to Equity
1.19
Debt to Assets
47.80%
Equity Ratio
40.28%
Cash Flow Analysis
Operating Cash Flow Ratio
30.35%
Free Cash Flow Ratio
-24.89%
CapEx to Revenue
55.24%
Dividends Paid
$94.00M
Stock Buybacks
$335.31M
Total Shareholder Returns
$429.32M
Cash Position Change
-26.87%
Key Takeaways (2023 FY)
Revenue declined by 0.26839478132263%, indicating potential market challenges
Detailed Growth Metrics
Core Performance
Revenue
-0.27%
Net Income
-193.68%
EPS
-211.43%
Operating Income
47.08%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-13.01%
Operating Cash Flow
3.00%
Free Cash Flow
-1.12%
Balance Sheet Health
Assets
-6.52%
Debt
8.23%
Book Value per Share
-4.58%
Inventory
100.00%
Shareholder Returns
Dividends per Share
-1.16%
Shares Outstanding
-11.69%
Long Term Trends
3Y Revenue/Share
27.29%
5Y Revenue/Share
6.36%
3Y Dividend/Share
-0.54%
5Y Dividend/Share
-0.72%